AL-0912
N/A
Report date: 2026/01/13 20:00:24
NME
Base Information
Drug NameAL-0912
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Aosaikang Pharmaceutical Co LtdInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical SciencesJiangsu Aosaikang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A